Fluxus clinical environment
Fluxus is an innovative clinical environment that represents a paradigm shift for cancer analysis in tumour evolution and surgical planning.
By assisting with cutting-edge technologies such as AI and D/L, Avamed Synergy enables healthcare professionals to deliver optimal patient outcomes with unparalleled efficiency, consolidating its status as a pioneer in the Spanish healthcare industry.
Our aim is to anticipate the dynamics of tumour growth and its classification, allowing the elimination of possible unwanted complications in treatment and during surgery, improving outcomes and impacts on patients.
Fluxus Technology
Fluxus by Avamed Synergy is the world’s first predictive model of tumour-host spatial localization interface and space cells generated by artificial intelligence. Fluxus integrates single uncertainty quantification and multiscale data, which reduces tumour-host uncertainty and predicts tumour evolution.
The platform introduces a notable differentiation that lies in its predictive modelling, a feature that distinguishes it from existing offers on the market. It’s not just about seeing the tumour, but understanding its future behaviour with the host, which fundamentally changes surgical planning and treatment approaches.
Social impact of the proyect
Fluxus stands out for providing exceptional services across the entire spectrum of oncology and surgical practice. Its focus on precision, safety and patient-centred care makes it a valuable asset in the ongoing fight against cancer. The great social benefit that this project can bring in its progress and development is to advance on different social challenges.
Patients
Complete and accurate diagnostic scope:
- Increased life expectancy.
- Better prediction and recovery.
- Less radiation and faster attention.
Users
High accuracy in diagnosis and approach:
- Anticipation in tumour detection.
- Reduce false negative diagnoses by 95%.
- Reduction of surgical errors, achieving greater precision.
Society
Save money and save patients’ lives:
- €2MM saved in Europe per year.
- 45,000 €/u to an MRI scanner costing between 1 and 2 MM€.
- More MRI available for cancer screening.
Big impacts
Fluxus optimizes the use of resources in healthcare, helping to reduce energy consumption and reduce the carbon footprint of medical facilities by streamlining diagnostic processes. By improving the accuracy of medical diagnoses and surgical planning, Fluxus directly contributes to improving public health and patient safety by reducing risks associated with misdiagnosis and surgical complications. Our innovation respects cultural diversity and ethical considerations in health care, alienating itself from global standards for ethical medical practices and contributing to the preservation of cultural sensitivities in treatment and care.
Avamed Synergy’s commitment to sustainability and social responsibility is closely aligned with the UN Sustainable Development Goals, by improving patient care outcomes while advancing technological innovation in healthcare infrastructure.
Compliance with and contribution to EU policy.
- EU health policies: Our innovation supports the EU’s 2030 health policy framework, especially in personalised medicine and digital healthcare solutions, improving the accuracy of diagnosis and treatment planning, improving patient outcomes.
- Regulatory compliance: Fluxus is developed with strict compliance with the European Union medical device regulations, ensuring patient safety and data protection. This includes compliance with the General Data Protection Regulation (GDPR) for patient data and the Medical Devices Regulation (MDR) for software as a healthcare product.
